[embedded content]
What You Should Know:
– Google Health and Apollo Radiology International are joining forces to tackle some of the country’s biggest health challenges – tuberculosis (TB), lung cancer, and breast cancer – using AI-powered…
Continue Reading
What You Should Know:
AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).The acquisition marks a major step forward in AstraZeneca delivering on its ambition to…
Continue Reading
iCAD introduces advanced features to streamline mammogram interpretation, enhancing radiologists’ efficiency and interpretability. The new capabilities include limiting lesion marks, color-coding abnormalities, and providing customizable score ranges. These enhancements aim to improve the readability…
Continue Reading
What You Should Know:
– The American Cancer Society (ACS) and Color Health announced today a significant expansion of their existing program, creating a first-of-its-kind comprehensive cancer solution for employers and labor unions. This enhanced…
Continue Reading
What You Should Know:
– Lunit (KRX:328130.KQ), a provider of AI-powered cancer diagnostics and therapeutics solutions, announced today two significant commercial agreements that mark its continued European expansion.
– These strategic deals will bring Lunit’s AI-powered…
Continue Reading
Gleneagles Hospital, part of the international private hospital group IHH Healthcare, has partnered with medical AI providers to bolster its diagnostics capability in Singapore and Hong Kong. On one hand, the radiology department at Gleneagles Hong…
Continue Reading
What You Should Know:
– Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
– The first-of-its-kind contribution will significantly enhance the NCI’s planned…
Continue Reading
Transforming breast cancer detection, ScreenPoint Medical’s Transpara Breast AI integrates seamlessly into Johns Hopkins Medicine’s renowned breast imaging services. This collaboration harnesses cutting-edge technology and clinical expertise to enhance screening accuracy and patient outcomes….
Continue Reading
Progress in sequencing technologies and clinical experiments has revolutionized immunotherapy on solid and hematologic malignancies. However, the benefits of immunotherapy are limited to specific patient subsets, posing challenges for broader application. To improve its…
Continue Reading
What You Should Know:
– The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC’s oncology care…
Continue Reading
